Home » Stocks » Progyny

Progyny, Inc. (PGNY)

Stock Price: $27.95 USD 0.55 (2.01%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
After-hours: $27.96 +0.01 (0.04%) Oct 23, 7:28 PM

Stock Price Chart

Key Info

Market Cap 2.40B
Revenue (ttm) 271.95M
Net Income (ttm) -10.37M
Shares Out 85.98M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $27.95
Previous Close $27.40
Change ($) 0.55
Change (%) 2.01%
Day's Open 27.60
Day's Range 27.26 - 28.06
Day's Volume 341,266
52-Week Range 13.29 - 36.50

More Stats

Market Cap 2.40B
Enterprise Value 2.31B
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 85.98M
Float 35.27M
EPS (basic) -0.78
EPS (diluted) -0.99
FCF / Share 0.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.47%
Payout Ratio n/a
Shares Short 3.69M
Short Ratio 4.83
Short % of Float 10.45%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 213.85
PS Ratio 8.84
PB Ratio 19.71
Revenue 271.95M
Operating Income 6.25M
Net Income -10.37M
Free Cash Flow 11.24M
Net Cash 91.38M
Net Cash / Share 1.06
Gross Margin 16.73%
Operating Margin 2.30%
Profit Margin -3.80%
FCF Margin 4.13%
ROA 3.25%
ROE -15.21%
ROIC -49.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 5
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$34.67*
(24.04% upside)
Low
30.0
Current: $27.95
High
44.0
Target: 34.67
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017
Revenue23010548.58
Revenue Growth117.92%116.94%-
Gross Profit45.5119.437.40
Operating Income9.68-3.45-11.01
Net Income-8.570.66-12.45
Shares Outstanding20.745.545.68
Earnings Per Share-0.410.04-2.37
Operating Cash Flow-1.532.27-9.47
Capital Expenditures-2.96-0.58-0.61
Free Cash Flow-4.491.69-10.09
Cash & Equivalents80.380.134.69
Total Debt-0.255.19
Net Cash / Debt80.38-0.13-0.50
Assets15041.3234.96
Liabilities36.1630.2024.27
Book Value114-95.12-97.62
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Progyny, Inc.
Country United States
Employees 167
CEO David J. Schlanger

Stock Information

Ticker Symbol PGNY
Stock Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Unique Identifier NASDAQ: PGNY
IPO Date October 25, 2019

Description

Progyny, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clients and their employees. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.